首页> 外文OA文献 >Prophylactic Administration of Bacterially Derived Immunomodulators Improves the Outcome of Influenza Virus Infection in a Murine Model▿
【2h】

Prophylactic Administration of Bacterially Derived Immunomodulators Improves the Outcome of Influenza Virus Infection in a Murine Model▿

机译:预防性施用细菌衍生的免疫调节剂可改善小鼠模型中流感病毒感染的结果▿

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Prophylactic or therapeutic immunomodulation is an antigen-independent strategy that induces nonspecific immune system activation, thereby enhancing host defense to disease. In this study, we investigated the effect of prophylactic immunomodulation on the outcome of influenza virus infection using three bacterially derived immune-enhancing agents known for promoting distinct immunological profiles. BALB/c mice were treated nasally with either cholera toxin (CT), a mutant form of the CT-related Escherichia coli heat-labile enterotoxin designated LT(R192G), or CpG oligodeoxynucleotide. Mice were subsequently challenged with a lethal dose of influenza A/PR/8/34 virus 24 h after the last immunomodulation treatment and either monitored for survival or sacrificed postchallenge for viral and immunological analysis. Treatment with the three immunomodulators prevented or delayed mortality and weight loss, but only CT and LT(R192G) significantly reduced initial lung viral loads as measured by plaque assay. Analysis performed 4 days postinfection indicated that prophylactic treatments with CT, LT(R192G), or CpG resulted in significantly increased numbers of CD4 T cells, B cells, and dendritic cells and altered costimulatory marker expression in the airways of infected mice, coinciding with reduced expression of pulmonary chemokines and the appearance of inducible bronchus-associated lymphoid tissue-like structures in the lungs. Collectively, these results suggest that, despite different immunomodulatory mechanisms, CT, LT(R192G), and CpG induce an initial inflammatory process and enhance the immune response to primary influenza virus challenge while preventing potentially damaging chemokine expression. These studies provide insight into the immunological parameters and immune modulation strategies that have the potential to enhance the nonspecific host response to influenza virus infection.
机译:预防性或治疗性免疫调节是一种非抗原依赖性策略,可诱导非特异性免疫系统激活,从而增强宿主对疾病的防御能力。在这项研究中,我们调查了预防性免疫调节对流感病毒感染结局的影响,使用了三种细菌衍生的免疫增强剂来促进独特的免疫学特征。 BALB / c小鼠经鼻处理霍乱毒素(CT),一种与CT相关的大肠杆菌热不稳定肠毒素的突变体形式(LT(R192G))或CpG寡脱氧核苷酸。最后一次免疫调节处理后24小时,用致死剂量的A / PR / 8/34流感病毒对小鼠进行攻击,并监测其存活率或攻击后牺牲以进行病毒和免疫学分析。用三种免疫调节剂进行的治疗可预防或延迟死亡率和体重减轻,但仅通过斑块测定法,CT和LT(R192G)可以显着降低初始肺病毒载量。感染后4天进行的分析表明,用CT,LT(R192G)或CpG进行的预防性治疗可导致感染的小鼠气道中CD4 T细胞,B细胞和树突状细胞的数量显着增加,并且共刺激标记物表达发生改变,肺趋化因子的表达和肺中可诱导的支气管相关淋巴样组织样结构的出现。总体而言,这些结果表明,尽管免疫调节机制不同,但CT,LT(R192G)和CpG诱导了初始炎症过程并增强了对原发性流感病毒攻击的免疫反应,同时防止了可能破坏趋化因子的表达。这些研究提供了对免疫学参数和免疫调节策略的深入了解,这些免疫学参数和免疫调节策略有可能增强对流感病毒感染的非特异性宿主反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号